DH Enchantment, Inc. (ENMI)
OTCMKTS
· Delayed Price · Currency is USD
0.0038
-0.0009 (-19.15%)
Mar 31, 2025, 4:00 PM EST
DH Enchantment Revenue
DH Enchantment had revenue of $387.55K in the quarter ending December 31, 2024, a decrease of -34.12%. This brings the company's revenue in the last twelve months to $-42.87K, down -103.10% year-over-year. In the fiscal year ending March 31, 2024, DH Enchantment had annual revenue of $686.00, down -95.46%.
Revenue (ttm)
-42.87K
Revenue Growth
-103.10%
P/S Ratio
n/a
Revenue / Employee
-42.87K
Employees
1
Market Cap
14.56M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 686.00 | -14.41K | -95.46% |
Mar 31, 2023 | 15.10K | -533.47K | -97.25% |
Mar 31, 2022 | 548.57K | 337.02K | 159.31% |
Mar 31, 2021 | 211.55K | 169.31K | 400.81% |
Mar 31, 2010 | 42.24K | 35.23K | 502.41% |
Mar 31, 2009 | Pro | Pro | Pro |
Mar 31, 2008 | Pro | Pro | Pro |
Mar 31, 2007 | Pro | Pro | Pro |
Mar 31, 2006 | Pro | Pro | Pro |
Mar 31, 2005 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.76B |
SS Innovations International | 16.04M |
Veradigm | 588.02M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 200.90M |
Northwest Biotherapeutics | 1.60M |
Silence Therapeutics | 43.26M |
American Oncology Network | 1.76B |